Sfoglia per Autore
HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa
2014-01-01 Noccioli, C; Bertoli, A; Agus, E; DE LOGU, Alessandro; Pistelli, L.
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents
2013-01-01 Arridu, A.; Meleddu, R.; Bianco, Giulia; Distinto, Simona; DE LOGU, Alessandro; Matyus, P.; Maccioni, Elias
Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection
2013-01-01 Poce, G; Bates, Rh; Alfonso, S; Cocozza, M; Porretta, Gc; Ballell, L; Rullas, J; Ortega, F; DE LOGU, Alessandro; Agus, E; LA ROSA, Valentina; Pasca, Mr; De Rossi, E; Wae, B; Franzblau, Sg; Manetti, F; Botta, M; Biava, M.
Saggi e dosaggi microbiologici della Farmacopea
2012-01-01 DE LOGU, Alessandro
Aspetti microbiologici della produzione farmaceutica
2012-01-01 DE LOGU, Alessandro
Stafilococchi
2012-01-01 DE LOGU, Alessandro
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212
2012-01-01 LA ROSA, Valentina; Poce, G; ORTIZ CANSECO, J; Buroni, S; Pasca, Mr; Biava, M; Raju, Rm; Poretta, Gc; Alfons, S; Battilocchio, C; Javid, B; Sorrentino, F; Ioerger, Tr; Sacchettini, Jc; Manetti, F; Botta, M.; DE LOGU, Alessandro; Rubin, Ej; DE ROSSI, E.
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug
2011-01-01 Canseco, Jo; LA ROSA, Valentina; Luhaj, A; Battaglia, S; Buroni, S; Biava, M; DE LOGU, Alessandro; Manetti, F; Botta, M; De Rossi, E.
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach
2011-01-01 Biava, M; Porretta, Gc; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, Alessandro; Manetti, F; Botta, M.
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases
2011-01-01 Casu, Laura; Cottiglia, Filippo; Leonti, Marco; DE LOGU, Alessandro; Agus, E; Tse Dinh, Yc; Lombardo, V; Sissi, C.
Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis.
2010-01-01 Agus, E; Biava, M; Porretta, Gc; Poce, G; Serra, N; Sanna, A; De Rossi, E; Piras, Cc; Manetti, F; Botta, M; DE LOGU, Alessandro
BM 579: a novel pyrrole derivative with improved antimycobacterial activity
2010-01-01 Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; Manetti, F; Botta, M.
Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari
2010-01-01 Agus, E; Biava, M; Porretta, Gc; Poce, G; De Rossi, E; Manetti, F; Botta, M; DE LOGU, Alessandro
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action.
2010-01-01 Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; De Rossi, E; Manetti, F; Botta, M.
Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero
2010-01-01 Agus, E; Sanna, A; Piras, Cc; Serra, N; DE LOGU, Alessandro
dentification of a new Chemical Class of Potent Antimycobacterial Compounds
2010-01-01 Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; Manetti, F; Botta, M.
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin
2010-01-01 Biava, M; Porretta, Gc; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, Alessandro; Serra, N; Manetti, F; Botta, M.
Saggi e dosaggi microbiologici della Farmacopea
2009-01-01 DE LOGU, Alessandro
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis
2009-01-01 DE LOGU, Alessandro; LARISA H., Palchykovska; VALENTINA H., Kostina; Adriana, Sanna; Meleddu, Rita; Lorenza, Chisu; INNA V., Alexeeva; ANATOLY D., Shved
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action
2009-01-01 Biava, M; Porretta, Gc; Battilocchio, C; Poce, G; Pompei, R; DE LOGU, Alessandro; Manetti, F; Botta, M.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| HPLC-DAD-MS analysis and antiviral activity of different extracts and isolated costituents from Bituminaria bituminosa | 1-gen-2014 | Noccioli, C; Bertoli, A; Agus, E; DE LOGU, Alessandro; Pistelli, L. | CHEMISTRY OF NATURAL COMPOUNDS | - |
| 2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents | 1-gen-2013 | Arridu, A.; Meleddu, R.; Bianco, Giulia; Distinto, Simona; DE LOGU, Alessandro; Matyus, P.; Maccioni, Elias | - | - |
| Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection | 1-gen-2013 | Poce, G; Bates, Rh; Alfonso, S; Cocozza, M; Porretta, Gc; Ballell, L; Rullas, J; Ortega, F; DE LOGU, Alessandro; Agus, E; LA ROSA, Valentina; Pasca, Mr; De Rossi, E; Wae, B; Franzblau, Sg; Manetti, F; Botta, M; Biava, M. | PLOS ONE | - |
| Saggi e dosaggi microbiologici della Farmacopea | 1-gen-2012 | DE LOGU, Alessandro | - | Edises |
| Aspetti microbiologici della produzione farmaceutica | 1-gen-2012 | DE LOGU, Alessandro | - | Edises |
| Stafilococchi | 1-gen-2012 | DE LOGU, Alessandro | - | Edises |
| MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 | 1-gen-2012 | LA ROSA, Valentina; Poce, G; ORTIZ CANSECO, J; Buroni, S; Pasca, Mr; Biava, M; Raju, Rm; Poretta, Gc; Alfons, S; Battilocchio, C; Javid, B; Sorrentino, F; Ioerger, Tr; Sacchettini, Jc; Manetti, F; Botta, M.; DE LOGU, Alessandro; Rubin, Ej; DE ROSSI, E. | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | - |
| The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug | 1-gen-2011 | Canseco, Jo; LA ROSA, Valentina; Luhaj, A; Battaglia, S; Buroni, S; Biava, M; DE LOGU, Alessandro; Manetti, F; Botta, M; De Rossi, E. | - | FEMS |
| Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach | 1-gen-2011 | Biava, M; Porretta, Gc; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, Alessandro; Manetti, F; Botta, M. | CHEMMEDCHEM | - |
| Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases | 1-gen-2011 | Casu, Laura; Cottiglia, Filippo; Leonti, Marco; DE LOGU, Alessandro; Agus, E; Tse Dinh, Yc; Lombardo, V; Sissi, C. | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
| Design, synthesis and microbiological characterization of 1,5-diphenyl and 1,5-diaryl-2-ethylpyrrole derivatives as new potential agents of infections sustained by MDR and XDR Mycobacterium tuberculosis. | 1-gen-2010 | Agus, E; Biava, M; Porretta, Gc; Poce, G; Serra, N; Sanna, A; De Rossi, E; Piras, Cc; Manetti, F; Botta, M; DE LOGU, Alessandro | - | - |
| BM 579: a novel pyrrole derivative with improved antimycobacterial activity | 1-gen-2010 | Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; Manetti, F; Botta, M. | - | - |
| Individuazione di nuovi target in MDR e XDR Mycobacterium tuberculosis mediante 1,5-difenil- e 1,5-diaril-2-etil-pirroli per lo sviluppo di nuovi agenti antitubercolari | 1-gen-2010 | Agus, E; Biava, M; Porretta, Gc; Poce, G; De Rossi, E; Manetti, F; Botta, M; DE LOGU, Alessandro | - | - |
| New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action. | 1-gen-2010 | Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; De Rossi, E; Manetti, F; Botta, M. | - | - |
| Effetto di Inibitori delle COX-1 e COX-2 sullo sviluppo del biofilm di Candida albicans: studio della associazione di FANS e derivati azolici per la profilassi delle infezioni fungine contratte in ambiente ospedaliero | 1-gen-2010 | Agus, E; Sanna, A; Piras, Cc; Serra, N; DE LOGU, Alessandro | - | - |
| dentification of a new Chemical Class of Potent Antimycobacterial Compounds | 1-gen-2010 | Biava, M; Porretta, Gc; Poce, G; Alfonso, S; Battilocchio, C; DE LOGU, Alessandro; Manetti, F; Botta, M. | - | - |
| Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin | 1-gen-2010 | Biava, M; Porretta, Gc; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, Alessandro; Serra, N; Manetti, F; Botta, M. | BIOORGANIC & MEDICINAL CHEMISTRY | - |
| Saggi e dosaggi microbiologici della Farmacopea | 1-gen-2009 | DE LOGU, Alessandro | - | - |
| Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis | 1-gen-2009 | DE LOGU, Alessandro; LARISA H., Palchykovska; VALENTINA H., Kostina; Adriana, Sanna; Meleddu, Rita; Lorenza, Chisu; INNA V., Alexeeva; ANATOLY D., Shved | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | - |
| Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action | 1-gen-2009 | Biava, M; Porretta, Gc; Battilocchio, C; Poce, G; Pompei, R; DE LOGU, Alessandro; Manetti, F; Botta, M. | - | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile